ETHINYL ESTRADIOL; NORELGESTROMIN
| Brand name | ETHINYL ESTRADIOL AND NORELGESTROMIN |
|---|---|
| Active ingredient | ETHINYL ESTRADIOL; NORELGESTROMIN |
| Strength | 0.035MG/24HR;0.15MG/24HR |
| Dosage form | FILM, EXTENDED RELEASE |
| Route | TRANSDERMAL |
| Modality | Small molecule |
| FDA approval | February 2021 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.